Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

Schlesinger, Yeshayahu, Straussman, Ravid, Keshet, Ilana, Farkash, Shlomit, Hecht, Merav, Zimmerman, Joseph, Eden, Eran, Yakhini, Zohar +5 more·2007·Nature Genetics

Cited by (1,000)

Items 301–400 of 1,000

  1. Histone Modifications in Cancer Biology and Prognosis
    Siavash K. Kurdistani · 2010 · Springer eBooks
  2. Linking DNA Methyltransferases to Epigenetic Marks and Nucleosome Structure Genome-wide in Human Tumor Cells
    Bilian Jin, Jason Ernst, Rochelle L. Tiedemann, Hongyan Xu, Suhas Sureshchandra, M Kellis, Stephen Dalton, Chen Liu, Jeong-Hyeon Choi, Keith D. Robertson · 2012 · Cell Reports
  3. Two competing mechanisms of DNMT3A recruitment regulate the dynamics of de novo DNA methylation at PRC1-targeted CpG islands
    Daniel N. Weinberg, Phillip Rosenbaum, Xiao Chen, Douglas Barrows, Cynthia Horth, Matthew R. Marunde, Irina K Popova, Zachary B Gillespie, Michael‐Christopher Keogh, Chao Lü et al. · 2021 · Nature Genetics
  4. Breast cancer epigenetics: normal human mammary epithelial cells as a model system
    Rebecca A. Hinshelwood, Susan J. Clark · 2008 · Journal of Molecular Medicine
  5. The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
    Alastair Davies, Amina Zoubeidi, Luke A. Selth · 2019 · Endocrine Related Cancer
  6. The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
    Martí Duran‐Ferrer, Guillem Clot, Ferran Nadeu, Renée Beekman, Tycho Baumann, Jessica Nordlund, Yanara Marincevic-Zuniga, Gudmar Lönnerholm, Alfredo Rivas‐Delgado, Silvia Martín et al. · 2020 · Nature Cancer
  7. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
    Xin Hu, Marcos R. Estecio, Runzhe Chen, Alexandre Reuben, Linghua Wang, Junya Fujimoto, Jian Carrot‐Zhang, Nicholas McGranahan, Lisha Ying, Junya Fukuoka et al. · 2021 · Nature Communications
  8. A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers
    Thomas L. Dunwell, Luke B. Hesson, Tibor A. Rauch, Lihui Wang, Richard E. Clark, Ashraf Dallol, Dean Gentle, Daniel Robin Catchpoole, Eamonn Richard Maher, Gerd P. Pfeifer et al. · 2010 · Molecular Cancer
  9. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma
    Ole Ammerpohl, Johann Pratschke, Clemens Schafmayer, Andrea Haake, Wladimir Faber, Oliver von Kampen, Mario Brosch, Bence Sipos, Witigo V Schönfels, Katharina Balschun et al. · 2011 · International Journal of Cancer
  10. Transcriptional regulation of cellular senescence
    Lanigan, F, Geraghty, J G, Bracken, A P · 2011 · Oncogene
  11. Epigenomic Reorganization of the Clustered Hox Genes in Embryonic Stem Cells Induced by Retinoic Acid
    Vasundhra Kashyap, Lorraine J. Gudas, Fabienne A. Brenet, Patricia Funk, Agnes J. Viale, Joseph Michael Scandura · 2010 · Journal of Biological Chemistry
  12. Chapter 9 Epigenetic Gene Regulation in Cancer
    Esteban Ballestar, Manel Esteller · 2008 · Advances in genetics
  13. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation
    Junji Koya, Keisuke Kataoka, Tomohiko Sato, Masashige Bando, Yuki Kato, Takako Tsuruta-Kishino, Hiroshi Kobayashi, Kensuke Narukawa, Hiroyuki Miyoshi, Katsuhiko Shirahige et al. · 2016 · Nature Communications
  14. Distinct chromatin signatures of DNA hypomethylation in aging and cancer
    Raúl F. Pérez, Juan Ramón Tejedor, Gustavo F. Bayón, Agustín F. Fernández, Mario F. Fraga · 2018 · Aging Cell
  15. Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer
    Bradley P. Coe, Kelsie L. Thu, Sarit Aviel‐Ronen, Emily A. Vucic, Adi F. Gazdar, Stephen C. Lam, Ming‐Sound Tsao, Wan L. Lam · 2013 · PLoS ONE
  16. Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells
    Warren C. Fiskus, Kate Buckley, Rekha Rao, Aditya Mandawat, Yonghua Yang, Rajeshree Joshi, Yongchao Wang, Ramesh Balusu, Jianguang Chen, Sanjay Koul et al. · 2009 · Cancer Biology & Therapy
  17. Genome structure‐based screening identified epigenetically silenced microRNA associated with invasiveness in non‐small‐cell lung cancer
    Kousuke Watanabe, Noriko Emoto, Emi Hamano, Mitsuhiro Sunohara, Masanori Kawakami, Hidenori Kage, Kentaro Kitano, Jun Nakajima, Akiteru Goto, Masashi Fukayama et al. · 2011 · International Journal of Cancer
  18. Roles of Achaete-Scute Homologue 1 in DKK1 and E-cadherin Repression and Neuroendocrine Differentiation in Lung Cancer
    Hirotaka Osada, Shuta Tomida, Yasushi Yatabe, Yoshio Tatematsu, Toshiyuki Takeuchi, Hideki Murakami, Yutaka Kondo, Yoshitaka Sekido, Takashi Takahashi · 2008 · Cancer Research
  19. Epigenetics in multiple myeloma: From mechanisms to therapy
    Mohammad Alzrigat, Alba Atienza Párraga, Helena Jernberg‐Wiklund · 2017 · Seminars in Cancer Biology
  20. Distinct roles of DNMT1-dependent and DNMT1-independent methylation patterns in the genome of mouse embryonic stem cells
    Zhiguang Li, Hongzheng Dai, Suzanne N. Martos, Beisi Xu, Yang Gao, Li Teng, Guangjing Zhu, Dustin E. Schones, Zhibin Wang · 2015 · Genome biology
  21. Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women
    Sarah M. Leonard, Wenbin Wei, Stuart I. Collins, Márcia Santos Pereira, A. Diyaf, Christothea Constandinou-Williams, Lawrence S. Young, Sally Roberts, Ciaran B. J. Woodman · 2012 · Carcinogenesis
  22. Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension
    Malik Bisserier, Prabhu Mathiyalagan, Shihong Zhang, Firas Elmastour, Peter Dorfmüller, Marc J.C. Humbert, Gregory David, Sima T. Tarzami, Thomas Weber, Frédéric Perros et al. · 2021 · Circulation
  23. Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia
    Matthew P. Hanley, Maria A. Hahn, A X Li, Xiwei Wu, Jianan Lin, J Wang, Audrey H. Choi, Zhengqing Ouyang, Yuman Fong, Gerd P. Pfeifer et al. · 2017 · Oncogene
  24. Epigenetics in Acute Myeloid Leukemia
    Christoph Plass, Christopher C. Oakes, William G. Blum, Guido Marcucci · 2008 · Seminars in Oncology
  25. Epigenetic Control of the Tumor Microenvironment
    David L. Marks, Rachel LO Olson, Martín E. Fernández-Zapico · 2016 · Epigenomics
  26. Genome-wide epigenomic profiling for biomarker discovery
    René A. M. Dirks, Hendrik G. Stunnenberg, Hendrik Marks · 2016 · Clinical Epigenetics
  27. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing
    Xudong Wu, Yanhua Gong, Jiping Yue, Boqin Qiang, Jiangang Yuan, Xiaozhong Peng · 2008 · Nucleic Acids Research
  28. Epigenetic regulation of colon cancer and intestinal stem cells
    Saher Sue Hammoud, Bradley Robert Cairns, David A. Jones · 2013 · Current Opinion in Cell Biology
  29. Dissecting DNA hypermethylation in cancer
    Marcos R. Estecio, Jean‐Pierre J. Issa · 2010 · FEBS Letters
  30. HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors
    Capucine Van Rechem, Majid Touka, Gaylor Boulay, Cateline Guérardel, Brian R. Rood, Dominique Leprince · 2008 · The International Journal of Biochemistry & Cell Biology
  31. Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer
    Marcos R. Estecio, Juan J. Gallegos, Céline Vallot, Ryan J. Castoro, Woonbok Chung, Shinji Maegawa, Yasuhiro Oki, Yutaka Kondo, Jaroslav Jelı́nek, Lanlan Shen et al. · 2010 · Genome Research
  32. Hot topics in epigenetic mechanisms of aging: 2011
    Berdasco, María, Esteller, Manel · 2012 · Aging Cell
  33. Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention
    Xuejiao Tian, Sai‐Yang Zhang, Hong‐Min Liu, Yanbing Zhang, Christopher Blair, Dan Mercola, Paolo Sassone‐Corsi, Xiaolin Zi · 2013 · Current Cancer Drug Targets
  34. Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis
    Marta Faryna, Carolin Konermann, Sebastian Aulmann, Justo Lorenzo Bermejo, Markus Brugger, Sven Diederichs, Joachim Rom, Dieter Weichenhan, Rainer Claus, Michael Rehli et al. · 2012 · The FASEB Journal
  35. DNA methylation-mediated control of learning and memory
    Nam‐Kyung Yu, Sung Hee Baek, Bong‐Kiun Kaang · 2011 · Molecular Brain
  36. DNMTs and Impact of CpG Content, Transcription Factors, Consensus Motifs, lncRNAs, and Histone Marks on DNA Methylation
    Jaqueline Loaeza‐Loaeza, Adriana S. Beltrán, Daniel Hernández‐Sotelo · 2020 · Genes
  37. Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9
    Daniel M. Sapozhnikov, Moshe Szyf · 2021 · Nature Communications
  38. Histone acetylation and chromatin signature in stem cell identity and cancer
    Vivek Shukla, Thomas Vaissière, Zdenko Herceg · 2007 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  39. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
    Mi Jeong Kwon, Sung-Su Kim, Yoon‐La Choi, Hun Soon Jung, Curt Balch, Su-Hyeong Kim, Yong Sang Song, Víctor E. Márquez, Kenneth P. Nephew, Young Kee Shin · 2010 · Carcinogenesis
  40. Polycomb CBX7 Promotes Initiation of Heritable Repression of Genes Frequently Silenced with Cancer-Specific DNA Hypermethylation
    Helai P. Mohammad, Yi Cai, Kelly M. McGarvey, Hariharan Easwaran, Leander Van Neste, Joyce Ellen Ohm, Heather M. O’Hagan, Stephen B. Baylin · 2009 · Cancer Research
  41. Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
    Jan Philipp Bewersdorf, Rory Michael Shallis, Maximilian F. Stahl, Amer Methqal Zeidan · 2019 · Therapeutic Advances in Hematology
  42. Functional DNA demethylation is accompanied by chromatin accessibility
    Kurinji Pandiyan, Jueng Soo You, Xiaojing Yang, Chao Dai, Xianghong Jasmine Zhou, Stephen B. Baylin, Peter A. Jones, Gangning Liang · 2013 · Nucleic Acids Research
  43. Polycomb Target Genes Are Silenced in Multiple Myeloma
    Antonia Kalushkova, Mårten Fryknäs, Miguel Lemaire, Charlotte Fristedt, Prasoon Agarwal, Maria Eriksson, Sarah Deleu, Peter Wisdom Atadja, Anders Österborg, Kenneth Nilsson et al. · 2010 · PLoS ONE
  44. Linking cell signaling and the epigenetic machinery
    Helai P. Mohammad, Stephen B. Baylin · 2010 · Nature Biotechnology
  45. Multifaceted role of EZH2 in breast and prostate tumorigenesis
    Gauri Deb, Vijay S. Thakur, Sanjay Gupta · 2013 · Epigenetics
  46. Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells
    Jin Yuan, M. Takeuchi, Masamitsu Negishi, Hideyuki Oguro, Hitoshi Ichikawa, Atsushi Iwama · 2011 · Leukemia
  47. Role of Polycomb in the control of transposable elements
    Angélique Deleris, Frédéric Berger, Sandra Duharcourt · 2021 · Trends in Genetics
  48. Genetic and epigenetic dependencies in colorectal cancer development
    Sehej Parmar, Hariharan Easwaran · 2022 · Gastroenterology report
  49. Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation
    Rush, Margaret, Appanah, Ruth, Lee, Sandra, Lam, Lucia L., Goyal, Preeti, Lorincz, Matthew C. · 2009 · Epigenetics
  50. Epigenetics and epigenetic alterations in pancreatic cancer.
    Noriyuki Omura, Michael Goggins · 2009 · PubMed Central
  51. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
    Ana-Luisa Silva, Sarah Natalie Dawson, Mark Johan Arends, Kiran Guttula, Nigel R. Hall, Ewen A. Cameron, Tim H.‐M. Huang, James D. Brenton, Simon Tavaré, Mariann Bienz et al. · 2014 · BMC Cancer
  52. Age-related epigenetic drift in the pathogenesis of MDS and AML
    Shinji Maegawa, Sheryl M. Gough, Naoko Watanabe‐Okochi, Yue Lu, Nianxiang Zhang, Ryan J. Castoro, Marcos R. Estecio, Jaroslav Jelı́nek, Shoudan Liang, Toshio Kitamura et al. · 2014 · Genome Research
  53. Cancer Genes Hypermethylated in Human Embryonic Stem Cells
    Vincenzo Calvanese, Angélica Horrillo, Abdelkrim Hmadcha, Beatriz Suárez-Álvarez, Agustín F. Fernández, Ester Lara, Sara Casado, Pablo R. Menéndez, Clara Bueno, Javier Garcı́a-Castro et al. · 2008 · PLoS ONE
  54. Array-based DNA methylation profiling in follicular lymphoma
    Ciarán Ó’Riain, Derville O’Shea, Youwen Yang, Rifca Le Dieu, John G. Gribben, Karin E. Summers, J Yeboah-Afari, Leena Bhaw, C Fleischmann, Charles A. Mein et al. · 2009 · Leukemia
  55. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer
    Michèle J. Hoffmann, Rainer Engers, Andrea R. Florl, Arie P. Otte, Mirko Müller, Wolfgang A. Schulz · 2007 · Cancer Biology & Therapy
  56. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
    Liudmila L. Kodach, Rutger J. Jacobs, Jarom Heijmans, Carel J.M. van Noesel, Alexandra M. J. Langers, Hein W. Verspaget, Daniël W. Hommes, G. Johan A. Offerhaus, Gijs R. VAN DEN BRINK, James C.H. Hardwick · 2010 · Carcinogenesis
  57. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks
    Stefan Deneberg, Philippe Guardiola, Andreas Lennartsson, Ying Qu, Verena Gaidzik, Odile Blanchet, Mohsen Karimi, Sofia Bengtzén, Hareth Nahi, Bertil Uggla et al. · 2011 · Blood
  58. Epigenomics of cancer – emerging new concepts
    Melanie R. Hassler, Gerda Egger · 2012 · Biochimie
  59. Concordant Epigenetic Silencing of Transforming Growth Factor-β Signaling Pathway Genes Occurs Early in Breast Carcinogenesis
    Rebecca A. Hinshelwood, Lily I. Huschtscha, John R. Melki, Clare Stirzaker, Andrea Abdipranoto, Bryce Vissel, Timothy Ravasi, Christine Anne Wells, David Arthur Hume, Roger R. Reddel et al. · 2007 · Cancer Research
  60. Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells
    Patrick J. Murphy, Benjamin R. Cipriany, Christopher B. Wallin, Chanyang Ju, Kylan Szeto, James A. Hagarman, Jaime J. Benítez, Harold G. Craighead, Paul D. Soloway · 2013 · Proceedings of the National Academy of Sciences
  61. Methylation Dynamics of RASSF1A and Its Impact on Cancer
    Giorgio Malpeli, Giulio Innamorati, Ilaria Decimo, Maria Bencivenga, Armel Hervé Nwabo Kamdje, Roberto Perris, Claudio Bassi · 2019 · Cancers
  62. Human Endometrial DNA Methylome Is Cycle-Dependent and Is Associated With Gene Expression Regulation
    Sahar Houshdaran, Zara Zelenko, Juan C. Irwin, Linda C. Giudice · 2014 · Molecular Endocrinology
  63. Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells
    Héctor Hernández‐Vargas, Maria Ouzounova, Florence Le Calvez‐Kelm, Marie-Pierre Lambert, Sandrine McKay‐Chopin, Sean V. Tavtigian, Alain Puisieux, Chantal Matar, Zdenko Herceg · 2011 · Epigenetics
  64. Epigenetic mechanisms in the biology of prostate cancer
    Wolfgang A. Schulz, Michèle J. Hoffmann · 2009 · Seminars in Cancer Biology
  65. Demethylating Agents in the Treatment of Cancer
    Paul Howell, Zixing Liu, Hung T. Khong · 2010 · Pharmaceuticals
  66. Environment, diet and CpG island methylation: Epigenetic signals in gastrointestinal neoplasia
    Ian T. Johnson, Nigel J. Belshaw · 2007 · Food and Chemical Toxicology
  67. Epigenomic Alterations in Localized and Advanced Prostate Cancer
    Pei‐Chun Lin, Ευγενία Γιαννοπούλου, Kyung Park, Juan Miguel Mosquera, Andrea Sboner, Ashutosh Kumar Tewari, Levi A. Garraway, Himisha Beltran, Mark A. Rubin, Olivier Elemento · 2013 · Neoplasia
  68. Non-canonical functions of the DNA methylome in gene regulation
    James P. Reddington, Sari Pennings, Richard R. Meehan · 2013 · Biochemical Journal
  69. Chromosomes and Expression in Human Testicular Germ‐Cell Tumors
    L. Looijenga, Ad J. M. Gillis, H. Stoop, R. Hersmus, J. Oosterhuis · 2007 · Annals of the New York Academy of Sciences
  70. Prognostic Significance of Overexpression of EZH2 and H3k27me3 Proteins in Gastric Cancer
    Longjun He, Mu-Yan Cai, Guo-Liang Xu, Xiao Hai Li, Zi-Jin Weng, Da-zhi Xu, Guangyu Luo, Sen-Lin Zhu, Dan Xie · 2012 · Asian Pacific Journal of Cancer Prevention
  71. Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
    Mi Jeong Kwon, Young Kee Shin · 2011 · International Journal of Molecular Sciences
  72. Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
    Iben Daugaard, Diana Dominguez, Tina Ellegaard Kjeldsen, Lasse S. Kristensen, Henrik Hager, Tomasz Kazimierz Wojdacz, Lise Lotte Hansen · 2016 · Scientific Reports
  73. 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
    Santiago Uribe‐Lewis, Rory Stark, Thomas D. Carroll, Mark Dunning, Martin Bachman, Yoko Ito, Lovorka Stojic, Silvia Halim, Sarah L. Vowler, Andy G. Lynch et al. · 2015 · Genome biology
  74. Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling
    Melanie R. Hassler, Walter Pulverer, Ranjani Lakshminarasimhan, Elisa Redl, Julia Hacker, Gavin D. Garland, Olaf Merkel, Ana‐Iris Schiefer, Ingrid Simonitsch‐Klupp, Lukas Kenner et al. · 2016 · Cell Reports
  75. PRC2 Is Required to Maintain Expression of the Maternal Gtl2-Rian-Mirg Locus by Preventing De Novo DNA Methylation in Mouse Embryonic Stem Cells
    Partha Pratim Das, David A. Hendrix, Effie Apostolou, Alice H. Buchner, Matthew C. Canver, Semir Beyaz, Damir Ljuboja, Rachael Kuintzle, Woojin Kim, Rahul Karnik et al. · 2015 · Cell Reports
  76. Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model
    Steven A. Belinsky, Marcie J. Grimes, Maria A. Picchi, Hugh D. Mitchell, Chris A. Stidley, Yohannes Tesfaigzi, Meghan M. Channell, Yanbin Liu, Robert A. Casero, Stephen B. Baylin et al. · 2011 · Cancer Research
  77. Epigenetic cancer therapy: Proof of concept and remaining challenges
    Cora Mund, Frank Lyko · 2010 · BioEssays
  78. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing
    Henriette O’Geen, Markéta Tomková, Jacquelyn A Combs, Emma Tilley, David Jay Segal · 2022 · Nucleic Acids Research
  79. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression
    Shichun Zheng, Eugene Andres Houseman, Zachary D. Morrison, Margaret Wrensch, Joseph S. Patoka, Christian Ramos, Daphne Adele Haas-Kogan, Sean Matthew McBride, Carmen J. Marsit, Brock C. Christensen et al. · 2011 · Neuro-Oncology
  80. Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
    Richard L. Momparler, Sylvie Côté, Louise F. Momparler, Youssef Idaghdour · 2014 · Clinical Epigenetics
  81. A Multifactorial Signature of DNA Sequence and Polycomb Binding Predicts Aberrant CpG Island Methylation
    Michael T. McCabe, Eva K. Lee, Paula M. Vertino · 2008 · Cancer Research
  82. Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancerThis paper is one of a selection of papers published in this Special Issue, entitled The 30th Annual International Asilomar Chromatin and Chromosomes Conference, and has undergone the Journal's usual peer review process.
    Randall S. Gieni, Michael J. Hendzel · 2009 · Biochemistry and Cell Biology
  83. Dissecting the role of aberrant DNA methylation in human leukaemia
    Giovanni Amabile, Annalisa Di Ruscio, Fabian Müller, Robert S. Welner, Henry He Yang, Alexander K. Ebralidze, Hong Zhang, Elena Levantini, Lihua Qi, Giovanni Martinelli et al. · 2015 · Nature Communications
  84. Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
    Tingting Li, Chao Yu, Shougang Zhuang · 2021 · Frontiers in Physiology
  85. Epigenetic Modification at Notch Responsive Promoters Blunts Efficacy of Inducing Notch Pathway Reactivation After Myocardial Infarction
    Giulia Felician, Chiara Collesi, Marina Lušić, Valentina C. Martinelli, Matteo Dal Ferro, Lorena Zentilin, Serena Zacchigna, Mauro Giacca · 2014 · Circulation Research
  86. Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target
    Prasoon Agarwal, Mohammad Alzrigat, Alba Atienza Párraga, Stefan Enroth, Umashankar Singh, Johanna S. Ungerstedt, Anders Österborg, Peter J. Brown, Anqi Ma, Jian Jun Jin et al. · 2016 · Oncotarget
  87. Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer
    John P. Thomson, Raffaele Ottaviano, Elif B. Unterberger, Harri Lempiäinen, Arne Müller, Rémi Terranova, Robert Scott Illingworth, Shaun Webb, Alastair R. W. Kerr, Marcus J. Lyall et al. · 2016 · Cancer Research
  88. Cancer-Related Epigenome Changes Associated with Reprogramming to Induced Pluripotent Stem Cells
    Joyce Ellen Ohm, Prashant Mali, Leander Van Neste, David Monty Berman, Liang Liang, Kurinji Pandiyan, Kimberly J. Briggs, Wei Zhang, Pedram Argani, Brian Wesley Simons et al. · 2010 · Cancer Research
  89. Molecular Processes Connecting DNA Methylation Patterns with DNA Methyltransferases and Histone Modifications in Mammalian Genomes
    Albert Jeltsch, Julian Broche, Pavel Bashtrykov · 2018 · Genes
  90. Epigenetic Factors in Cancer Development: Polycomb Group Proteins
    Andrea Piunti, Diego Pasini · 2010 · Future Oncology
  91. Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries
    Patompon Wongtrakoongate · 2015 · World Journal of Stem Cells
  92. An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia
    Tun Kiat Ko, Asif Javed, Kian Leong Lee, Thushangi N. Pathiraja, Xingliang Liu, Simeen Malik, Sheila Xinxuan Soh, Xiu Ting Heng, Naoto Takahashi, Joanna Hui Juan Tan et al. · 2020 · Blood
  93. Activation of Bmp2-Smad1 Signal and Its Regulation by Coordinated Alteration of H3K27 Trimethylation in Ras-Induced Senescence
    Atsushi Kaneda, Takanori Fujita, Motonobu Anai, Shogo Yamamoto, Genta Nagae, Masato Morikawa, Shingo Tsuji, Masanobu Oshima, Kohei Miyazono, Hiroyuki Aburatani · 2011 · PLoS Genetics
  94. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy
    Hideyuki Takeshima, Mika Wakabayashi, Naoko Hattori, Satoshi Yamashita, Toshikazu Ushijima · 2014 · Carcinogenesis
  95. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
    Thomas E. Bartlett, Kantaraja Chindera, Jacqueline R. McDermott, Charles E. Breeze, William Robert Cooke, Allison Jones, Daniel Reisel, Smita T. Karegodar, Rupali Arora, Stephan Beck et al. · 2016 · Nature Communications
  96. MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells
    Hasan N. Rajabi, Masayuki Hiraki, Donald W. Kufe · 2018 · Oncogene
  97. Lsh controls Hox gene silencing during development
    Sichuan Xi, Heming Zhu, Hong Xu, Anja Schmidtmann, Theresa M. Geiman, Kathrin Muegge · 2007 · Proceedings of the National Academy of Sciences
  98. Methylation analyses in liquid biopsy
    Delphine Lissa, Ana I. Robles · 2016 · Translational Lung Cancer Research
  99. Role of polycomb proteins Ring1A and Ring1Bin the epigenetic regulation of gene expression
    Miguel Vidal · 2009 · The International Journal of Developmental Biology
  100. Histone Modification Therapy of Cancer
    Chiara Biancotto, Gianmaria Frigè, Saverio Minucci · 2010 · Advances in genetics